Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 10.19
(10.04%)
CNY 10.19
(10.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.34 Billion CNY | -3.18% |
| 2022 | 2.42 Billion CNY | 6.05% |
| 2021 | 2.28 Billion CNY | 5.65% |
| 2020 | 2.16 Billion CNY | 13.41% |
| 2019 | 1.9 Billion CNY | -1.1% |
| 2018 | 1.92 Billion CNY | 22.1% |
| 2017 | 1.57 Billion CNY | 24.08% |
| 2016 | 1.27 Billion CNY | 5.85% |
| 2015 | 1.2 Billion CNY | 1.34% |
| 2014 | 1.18 Billion CNY | -1.27% |
| 2013 | 1.2 Billion CNY | -0.7% |
| 2012 | 1.21 Billion CNY | 4.34% |
| 2011 | 1.16 Billion CNY | 6.39% |
| 2010 | 1.09 Billion CNY | 176.83% |
| 2009 | 393.99 Million CNY | 3.91% |
| 2008 | 379.15 Million CNY | 49.03% |
| 2007 | 254.42 Million CNY | 68.24% |
| 2006 | 151.22 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.32 Billion CNY | -1.07% |
| 2024 Q3 | 2.27 Billion CNY | -1.58% |
| 2024 Q2 | 2.31 Billion CNY | -0.32% |
| 2023 Q1 | 2.43 Billion CNY | 0.33% |
| 2023 Q4 | 2.34 Billion CNY | -3.22% |
| 2023 FY | 2.34 Billion CNY | -3.18% |
| 2023 Q3 | 2.42 Billion CNY | -1.15% |
| 2023 Q2 | 2.45 Billion CNY | 0.87% |
| 2022 FY | 2.42 Billion CNY | 6.05% |
| 2022 Q4 | 2.42 Billion CNY | 2.54% |
| 2022 Q3 | 2.36 Billion CNY | 0.19% |
| 2022 Q2 | 2.35 Billion CNY | 2.96% |
| 2022 Q1 | 2.29 Billion CNY | 0.25% |
| 2021 Q4 | 2.28 Billion CNY | 1.64% |
| 2021 FY | 2.28 Billion CNY | 5.65% |
| 2021 Q1 | 2.18 Billion CNY | 1.01% |
| 2021 Q2 | 2.2 Billion CNY | 0.91% |
| 2021 Q3 | 2.24 Billion CNY | 1.98% |
| 2020 Q1 | 1.87 Billion CNY | -1.83% |
| 2020 Q2 | 2 Billion CNY | 7.0% |
| 2020 FY | 2.16 Billion CNY | 13.41% |
| 2020 Q4 | 2.16 Billion CNY | 4.59% |
| 2020 Q3 | 2.06 Billion CNY | 3.22% |
| 2019 Q4 | 1.9 Billion CNY | 1.16% |
| 2019 FY | 1.9 Billion CNY | -1.1% |
| 2019 Q3 | 1.88 Billion CNY | 0.96% |
| 2019 Q2 | 1.86 Billion CNY | -1.3% |
| 2019 Q1 | 1.89 Billion CNY | -1.89% |
| 2018 Q4 | 1.92 Billion CNY | 4.92% |
| 2018 Q1 | 1.65 Billion CNY | 4.64% |
| 2018 Q2 | 1.74 Billion CNY | 5.27% |
| 2018 Q3 | 1.83 Billion CNY | 5.64% |
| 2018 FY | 1.92 Billion CNY | 22.1% |
| 2017 Q2 | 1.44 Billion CNY | 2.52% |
| 2017 FY | 1.57 Billion CNY | 24.08% |
| 2017 Q4 | 1.57 Billion CNY | 4.79% |
| 2017 Q3 | 1.5 Billion CNY | 4.28% |
| 2017 Q1 | 1.41 Billion CNY | 10.76% |
| 2016 FY | 1.27 Billion CNY | 5.85% |
| 2016 Q2 | 1.22 Billion CNY | 2.08% |
| 2016 Q4 | 1.27 Billion CNY | 2.92% |
| 2016 Q3 | 1.23 Billion CNY | 1.09% |
| 2016 Q1 | 1.19 Billion CNY | -0.33% |
| 2015 Q2 | 1.19 Billion CNY | 0.27% |
| 2015 FY | 1.2 Billion CNY | 1.34% |
| 2015 Q4 | 1.2 Billion CNY | 0.5% |
| 2015 Q3 | 1.19 Billion CNY | 0.01% |
| 2015 Q1 | 1.19 Billion CNY | 0.56% |
| 2014 Q3 | 1.19 Billion CNY | 0.58% |
| 2014 FY | 1.18 Billion CNY | -1.27% |
| 2014 Q1 | 1.15 Billion CNY | -3.57% |
| 2014 Q2 | 1.18 Billion CNY | 2.15% |
| 2014 Q4 | 1.18 Billion CNY | -0.35% |
| 2013 Q3 | 1.19 Billion CNY | 0.8% |
| 2013 FY | 1.2 Billion CNY | -0.7% |
| 2013 Q4 | 1.2 Billion CNY | 0.72% |
| 2013 Q1 | 1.22 Billion CNY | 1.01% |
| 2013 Q2 | 1.18 Billion CNY | -3.17% |
| 2012 Q3 | 1.19 Billion CNY | 2.53% |
| 2012 Q4 | 1.21 Billion CNY | 1.49% |
| 2012 FY | 1.21 Billion CNY | 4.34% |
| 2012 Q1 | 1.18 Billion CNY | 2.24% |
| 2012 Q2 | 1.16 Billion CNY | -1.93% |
| 2011 Q4 | 1.16 Billion CNY | 1.92% |
| 2011 Q2 | 1.1 Billion CNY | -0.2% |
| 2011 Q1 | 1.11 Billion CNY | 1.84% |
| 2011 Q3 | 1.13 Billion CNY | 2.7% |
| 2011 FY | 1.16 Billion CNY | 6.39% |
| 2010 Q2 | 1.1 Billion CNY | 0.92% |
| 2010 Q1 | 1.09 Billion CNY | 177.98% |
| 2010 FY | 1.09 Billion CNY | 176.83% |
| 2010 Q4 | 1.09 Billion CNY | 1.55% |
| 2010 Q3 | 1.07 Billion CNY | -2.82% |
| 2009 Q4 | 393.99 Million CNY | 0.0% |
| 2009 FY | 393.99 Million CNY | 3.91% |
| 2008 FY | 379.15 Million CNY | 49.03% |
| 2007 FY | 254.42 Million CNY | 68.24% |
| 2006 FY | 151.22 Million CNY | 0.0% |